CTI BIOPHARMA CORP: capex
| Value | {"amount": 2011000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2010-01-01 – 2010-12-31 |
| Status | current |
| Entity | CTI BIOPHARMA CORP |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:57:44.285282+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ac0e91f8-e239-473e-aa2e-fa99d104317e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-12-103788 · Open the official SEC filing →Retrieved: 2026-08-19T08:57:44.285282+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000891293/capex/2010-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ac0e91f8-e239-473e-aa2e-fa99d104317e
History
- no predecessors — first report